Kip Ludwig is the Program Director for Neural Engineering at the National Institute of Neurological Disorders and Stroke (NINDS) out of the National Institutes of Health (NIH). He is the Scientific Lead for the Translational Devices Program at NINDS, is a Co-Lead of the Project Team responsible for developing and executing three of the six NIH Funding Opportunities Announcements for the White House B.R.A.I.N. Initiative, and led a trans-NIH planning team in developing the ~$250M Stimulating Peripheral Activity to Relieve Conditions (SPARC) Program to stimulate advances in neuromodulation therapies for organ systems. He currently serves as an advisor for the implementation of the S.P.A.R.C. Program.
Prior to coming to the NIH, Dr. Ludwig worked in Industry as a research scientist, where his team conceived, developed and demonstrated the chronic efficacy of a next-generation neural stimulation electrode for reducing blood pressure in both pre-clinical and clinical trials. Through his industry work he oversaw Good Laboratory Practice (GLP) and non-GLP studies enabling clinical trials in Europe and the United States, as well as participated in the protocol development and execution of those trials, leading to approval for sale in the European Union and a U.S. Pivotal trial. His electrode concept is now for sale in seven countries around the world. Dr. Ludwig received his Ph.D. in Bioengineering at the University of Michigan, followed by post-doctoral studies at the same institution. Dr. Ludwig’s academic work focused on neural decoding algorithms for brain-computer interfaces (BCI), signal processing techniques to denoise neural recordings, and advance materials to improve the chronic stimulating and recording performance of microelectrodes. Dr. Ludwig joined NINDS in 2011.
Active Funding Initiatives for Dr. Ludwig
Last Modified March 3, 2015